VALIRX PLC
Life science company developing therapeutics for oncology and women's health.
VAL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BLH13C52
- LEI:
- 213800VQKB9SJCQDET40
- Country:
- United Kingdom
- Address:
- STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH
- Website:
- https://www.valirx.com/
Description
ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-12-18 17:41 |
Second Price Monitoring Extn
|
English | 8.0 KB | ||
| 2018-12-18 17:36 |
Price Monitoring Extension
|
English | 8.0 KB | ||
| 2018-12-18 12:25 |
Issue of Equity / PDMR Shareholdings
|
English | 44.5 KB | ||
| 2018-12-18 08:00 |
Update on VAL401 - Peer-review Acceptance
|
English | 21.4 KB | ||
| 2018-12-10 08:00 |
Update on VAL201 Clinical Trial
|
English | 21.1 KB | ||
| 2018-11-05 08:00 |
Re scientific and investor meetings
|
English | 19.9 KB | ||
| 2018-11-01 08:15 |
Hardman & Co Research: ValiRx (VAL): VAL401 Phase II trial completed
|
English | 10.4 KB | ||
| 2018-10-24 09:00 |
Align Research Initiates Coverage
|
English | 16.2 KB | ||
| 2018-10-17 09:00 |
VAL201 in concluding stages of Phase I/II trial
|
English | 18.8 KB | ||
| 2018-10-15 14:00 |
VAL401 results shortly to be on ClinicalTrials.gov
|
English | 18.6 KB | ||
| 2018-09-25 09:00 |
Half-year Report
|
English | 260.5 KB | ||
| 2018-07-24 14:17 |
Result of General Meeting
|
English | 21.5 KB | ||
| 2018-07-24 14:17 |
Result of General Meeting
|
English | 21.2 KB | ||
| 2018-07-17 09:00 |
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
|
English | 23.9 KB | ||
| 2018-07-17 09:00 |
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
|
English | 23.6 KB |
Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for VALIRX PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for VALIRX PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
